Levodopa-carbidopa intestinal gel infusion (LCIG) in Parkinson disease with genetic mutations

Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers

(2022) Gian Pal et al.   ANNALS OF NEUROLOGY

Neuroimaging in Glucocerebrosidase‐Associated Parkinsonism: A Systematic Review

(2022) Massimo Filippi et al.   MOVEMENT DISORDERS

Intrajejunal Infusion of Levodopa/Carbidopa for Advanced Parkinson's Disease: A Systematic Review

(2021) Taiji Tsunemi et al.   MOVEMENT DISORDERS

Should we start integrating genetic data in decision-making on device-aided therapies in Parkinson disease? A Point of View

(2021) Philippe A. Salles et al.   PARKINSONISM & RELATED DISORDERS

DUOGLOBE : One‐Year Outcomes in a Real‐World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease

(2021) David G. Standaert et al.   Movement Disorders Clinical Practice

EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease

(2019) Haidar S. Dafsari et al.   MOVEMENT DISORDERS

Axial symptoms predict mortality in patients with Parkinson disease and subthalamic stimulation

(2019) Brian Lau et al.   NEUROLOGY

Levodopa-Carbidopa Intestinal Gel Monotherapy: GLORIA Registry Demographics, Efficacy, and Safety

(2019) Werner Poewe et al.   Journal of Parkinsons Disease

Parkinson disease

(2019) R. Balestrino et al.   EUROPEAN JOURNAL OF NEUROLOGY

Beyond 10 years of levodopa intestinal infusion experience: Analysis of mortality and its predictors

(2019) Carlo Alberto Artusi et al.   PARKINSONISM & RELATED DISORDERS

Glucocerebrosidase and Parkinson Disease: Molecular, Clinical, and Therapeutic Implications

(2018) Roberta Balestrino et al.   NEUROSCIENTIST

BDNF Polymorphism: A Review of Its Diagnostic and Clinical Relevance in Neurodegenerative Disorders

(2018) Ting Shen et al.   Aging and Disease

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial

(2018) Regina Katzenschlager et al.   LANCET NEUROLOGY

Genetic background and outcome of Deep Brain Stimulation in Parkinson's disease

(2018) Mario Giorgio Rizzone et al.   PARKINSONISM & RELATED DISORDERS

Rationale and patient selection for interventional therapies in Parkinson’s disease

(2018) Junaid Siddiqui et al.   Expert Review of Neurotherapeutics

NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases

(2017) Cornelis Blauwendraat et al.   NEUROBIOLOGY OF AGING

Survival and dementia inGBA-associated Parkinson's disease: The mutation matters

(2016) Roberto Cilia et al.   ANNALS OF NEUROLOGY

Peripheral neuropathy associated with levodopa-carbidopa intestinal infusion: a long-term prospective assessment

(2015) A. Merola et al.   EUROPEAN JOURNAL OF NEUROLOGY

MDS clinical diagnostic criteria for Parkinson's disease

(2015) Ronald B. Postuma et al.   MOVEMENT DISORDERS

EuroInf: AMulticenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease

(2014) Pablo Martinez-Martin et al.   MOVEMENT DISORDERS

Calibration of unified Parkinson's disease rating scale scores toMovementDisorder Society-unified Parkinson's disease rating scale scores

(2012) Christopher G. Goetz et al.   MOVEMENT DISORDERS

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

(2012) Irene Litvan et al.   MOVEMENT DISORDERS

Levodopa–carbidopa intestinal gel for treatment of advanced Parkinson’s disease

(2011) H.H. Fernandez et al.   CURRENT MEDICAL RESEARCH AND OPINION

Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease

(2011) Maurizio Zibetti et al.   MOVEMENT DISORDERS

Systematic review of levodopa dose equivalency reporting in Parkinson's disease

(2010) Claire L. Tomlinson et al.   MOVEMENT DISORDERS

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

(2008) Christopher G. Goetz et al.   MOVEMENT DISORDERS